Rising Pharmaceuticals, Inc. FDA Record
- Latest inspection VAI · Jan 28, 2019
- No warning letters matched by name
Rising Pharmaceuticals, Inc. has 9 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Rising Pharmaceuticals, Inc." is on file.
- Latest recall
- D-0348-2023 · Class II · Feb 15, 2023
- Latest inspection
- Jan 28, 2019 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 9 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Rising Pharmaceuticals, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 1 | 0 |
| 2022 | 0 | 0 | 0 | 1 | 0 |
| 2021 | 0 | 0 | 0 | 1 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 2 | 0 | 0 | 6 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Rising Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Rising Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0348-2023 | Class II | Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC… | Feb 15, 2023 |
| D-0573-2022 | Class II | Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for… | Feb 7, 2022 |
| D-0005-2022 | Class II | Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma… | Sep 2, 2021 |
| D-1368-2020 | Class III | Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application… | Nov 15, 2019 |
| D-1367-2020 | Class III | Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in… | Nov 15, 2019 |
| D-1054-2019 | Class II | Valsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC… | Mar 7, 2019 |
| D-1055-2019 | Class II | Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook… | Mar 7, 2019 |
| D-1052-2019 | Class II | Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC… | Mar 7, 2019 |
| D-1053-2019 | Class II | Valsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC… | Mar 7, 2019 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 28, 2019 | Saddle Brook, NJ | Drugs | Voluntary Action Indicated (VAI) | 3004813192 |
| Jan 16, 2019 | Saddle Brook, NJ | Food/Cosmetics | No Action Indicated (NAI) | 3004813192 |
| Sep 16, 2013 | Saddle Brook, NJ | Drugs | No Action Indicated (NAI) | 3004813192 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3004813192 | Saddle Brook, NJ | 3 | Jan 28, 2019 |
Rising Pharmaceuticals, Inc. and the FDA: common questions
Has Rising Pharmaceuticals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Rising Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Rising Pharmaceuticals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Rising Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Rising Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Jan 28, 2019 at Saddle Brook, NJ and was classified VAI. FDA has 3 inspections of Rising Pharmaceuticals, Inc. on file.
Has Rising Pharmaceuticals, Inc. had an FDA recall?
Yes. Rising Pharmaceuticals, Inc. has 9 FDA recalls on record. The most recent started Feb 15, 2023.
Need more than this page shows? Ask about Rising Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.